APSAD 2013: Beyond Harm Reduction: Acknowledging Psychoactive Benefits


PRISM will be presenting a panel discussion at the 2013 Australian Professional Society on Alcohol and other Drugs Scientific Conference 24-27 November in Brisbane. Our presentation, titled Beyond Harm Reduction: Acknowledging Psychoactive Benefits, will be chaired by Professor David Nutt (UK) and will feature short talks on the following topics and a subsequent panel discussion:

  • A review of currently prohibited drugs as psychoactive medicines
  • Substantial spirits: Exemptions for the religious use of psychoactive plants and substances in Australia
  • Considering the recreational benefits of currently prohibited drugs

The APSAD Conference’s focus is on drug problems, so our presentation is an unusual opportunity to provide a different and positive perspective.

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.


We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.


Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search